Published in Neurotoxicol Teratol on February 14, 2013
The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations. Neurotoxicol Teratol (2013) 0.88
Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy. Drug Alcohol Depend (2013) 0.82
Maternal methadone dose during pregnancy and infant clinical outcome: response to O'Grady et al. Neurotoxicol Teratol (2013) 0.75
Maternal methadone dose during pregnancy and infant clinical outcome. Neurotoxicol Teratol (2010) 2.22
Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med (2010) 3.84
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend (2005) 2.26
Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat (2008) 1.77
Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction (2010) 1.71
Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol (2003) 1.70
Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Fetal Neonatal Med (2012) 1.43
Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend (2003) 1.36
Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend (2004) 1.26
Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatr (2013) 1.26
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction (2012) 1.25
Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat (2006) 1.22
Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. Pediatrics (2008) 1.18
A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes. Subst Abuse (2013) 1.16
The Opioid dependent mother and newborn dyad: non-pharmacologic care. J Addict Med (2008) 1.14
Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat (2010) 1.14
Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned. Addiction (2012) 1.13
Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. Am J Addict (2013) 1.10
A partner's drug-using status impacts women's drug treatment outcome. Drug Alcohol Depend (2003) 1.08
ABM clinical protocol #21: Guidelines for breastfeeding and the drug-dependent woman. Breastfeed Med (2009) 1.08
The impact of managed care on drug-dependent pregnant and postpartum women and their children. Subst Use Misuse (2007) 1.07
Comment on: infants of opioid-dependent mothers: neurodevelopment at six months. Early Hum Dev (2015) 1.06
Variability in the evaluation and management of opiate-exposed newborns in Maryland. Clin Pediatr (Phila) (2007) 1.03
Prenatal methadone exposure and neonatal neurobehavioral functioning. Pediatr Res (2009) 1.02
Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs (2012) 1.02
Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care. Drug Alcohol Depend (2011) 1.02
Comparing homeless and domiciled pregnant substance dependent women on psychosocial characteristics and treatment outcomes. Drug Alcohol Depend (2003) 0.98
Cigarette smoking knowledge, attitudes, and practices of patients and staff at a perinatal substance abuse treatment center. J Subst Abuse Treat (2010) 0.98
Double jeopardy--drug and sex risks among Russian women who inject drugs: initial feasibility and efficacy results of a small randomized controlled trial. Subst Abuse Treat Prev Policy (2012) 0.97
Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome. J Perinat Med (2007) 0.97
Lessons learned from a randomized trial of fixed and escalating contingency management schedules in opioid-dependent pregnant women. Am J Drug Alcohol Abuse (2012) 0.97
Infant neurobehavior following prenatal exposure to methadone or buprenorphine: results from the neonatal intensive care unit network neurobehavioral scale. Subst Use Misuse (2010) 0.96
Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction (2012) 0.96
Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict (2010) 0.95
Parenting knowledge among substance abusing women in treatment. J Subst Abuse Treat (2004) 0.95
Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes. Drug Alcohol Depend (2012) 0.95
Fetal neurobehavioral effects of exposure to methadone or buprenorphine. Neurotoxicol Teratol (2010) 0.94
Neonatal abstinence scores in opioid-exposed and nonexposed neonates: a blinded comparison. J Opioid Manag (2011) 0.94
Twice stigmatized: provider's perspectives on drug-using women in the Republic of Georgia. J Psychoactive Drugs (2013) 0.94
Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study. Am J Drug Alcohol Abuse (2009) 0.93
The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients. Am J Drug Alcohol Abuse (2009) 0.93
Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict (2009) 0.92
Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, 2-ethyl-5-methyl-3,3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.92
Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients. Am J Addict (2009) 0.91
Partner violence impacts the psychosocial and psychiatric status of pregnant, drug-dependent women. Addict Behav (2004) 0.91
Exposure to violence among substance-dependent pregnant women and their children. J Subst Abuse Treat (2006) 0.90
Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Addiction (2012) 0.88
The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations. Neurotoxicol Teratol (2013) 0.88
Behavioral treatment + naltrexone reduces drug use and legal problems in the Republic of Georgia. Am J Drug Alcohol Abuse (2012) 0.87
Fetal assessment before and after dosing with buprenorphine or methadone. Addiction (2012) 0.87
Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research. Addiction (2012) 0.87
Multiple predictors of substance-abusing women's treatment and life outcomes: a prospective longitudinal study. Addict Behav (2003) 0.86
Maternal treatment with opioid analgesics and risk for birth defects: additional considerations. Am J Obstet Gynecol (2011) 0.85
A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine. Nicotine Tob Res (2013) 0.85
Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome. Addiction (2010) 0.85
Post-cesarean pain management of patients maintained on methadone or buprenorphine. Am J Addict (2006) 0.85
Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration. Clin Chem (2007) 0.85
Methadone trough levels in pregnancy. Am J Obstet Gynecol (2002) 0.84
Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates. Addiction (2012) 0.82
Gender and NAS: does sex matter? Drug Alcohol Depend (2010) 0.82
Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxification. Addiction (2012) 0.81
Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication. Addiction (2012) 0.81
Validation of a LC-APCI-MS/MS method for quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3,3-diphenylpyraline (EMDP) in infant plasma following protein precipitation. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.81
Usefulness of salivary trans-3'-hydroxycotinine concentration and trans-3'-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women. J Anal Toxicol (2005) 0.80
Methadone and metabolites in hair of methadone-assisted pregnant women and their infants. Ther Drug Monit (2012) 0.80
The efficacy of escalating and fixed contingency management reinforcement on illicit drug use in opioid-dependent pregnant women. Addict Disord Their Treat (2012) 0.79
Neonatal Abstinence Syndrome: Presentation and Treatment Considerations. J Addict Med (2016) 0.79
Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration. Ther Drug Monit (2010) 0.78
Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention. Drug Alcohol Depend (2013) 0.78
The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse. Am J Drug Alcohol Abuse (2010) 0.78
Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes. Addiction (2012) 0.78
Female partners of opioid-injecting men in the Republic of Georgia: an initial characterization. Subst Abuse Treat Prev Policy (2012) 0.78
Methadone and the causes of maternal and perinatal complications: a response to Pinto et al. "Substance abuse during pregnancy: effect on pregnancy outcomes" [Eur. J. Obstet. Gynecol. Reprod. Biol. 150 (2010) 137-141]. Eur J Obstet Gynecol Reprod Biol (2011) 0.77
Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine. Addiction (2012) 0.77
Nonserious adverse events in randomized trials with opioid-dependent pregnant women: direct versus indirect measurement. Am J Addict (2012) 0.77
Screening for Mood Disorder in Pregnant Substance-dependent Patients. Addict Disord Their Treat (2009) 0.77
Methadone and perinatal outcomes: another perspective. Am J Obstet Gynecol (2011) 0.76
Co-occurring psychiatric symptoms in opioid-dependent women: the prevalence of antenatal and postnatal depression. Am J Drug Alcohol Abuse (2012) 0.75
Commentary on Mactier et al. (2014): Methadone-assisted treatment and the complexity of influences on fetal development. Addiction (2014) 0.75
Cigarette Smoking and Neonatal Outcomes in Depressed and Non-Depressed Opioid-Dependent Agonist-Maintained Pregnant Patients. Addict Disord Their Treat (2011) 0.75
Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy. J Addict Dis (2012) 0.75